TVTX

TVTX

USD

Travere Therapeutics Inc. Common Stock

$34.510+1.910 (5.859%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$32.600

Haut

$34.605

Bas

$32.310

Volume

0.26M

Fondamentaux de l'Entreprise

Capitalisation Boursière

3.1B

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

2.25M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $12.91Actuel $34.510Haut $36.15

Actualités Connexes

BusinessWire

Travere Therapeutics to Participate at Upcoming Investor Conferences

Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced that company management will participate in the following upcoming investor conferences: Guggenheim's 2nd Annual Healthcare Innovation Conference Presenting

Voir plus
Travere Therapeutics to Participate at Upcoming Investor Conferences
Analyst Upgrades

Piper Sandler Maintains Neutral on Travere Therapeutics, Raises Price Target to $35

Piper Sandler analyst Allison Bratzel maintains Travere Therapeutics with a Neutral and raises the price target from $26 to $35.

Voir plus
Piper Sandler Maintains Neutral on Travere Therapeutics, Raises Price Target to $35
Analyst Upgrades

TD Cowen Maintains Buy on Travere Therapeutics, Raises Price Target to $40

TD Cowen analyst Tyler Van Buren maintains Travere Therapeutics with a Buy and raises the price target from $30 to $40.

Voir plus
TD Cowen Maintains Buy on Travere Therapeutics, Raises Price Target to $40
BusinessWire

Travere Therapeutics to Report Third Quarter 2025 Financial Results

Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced it will report third quarter 2025 financial results on Thursday, October 30, 2025, after the close of the U.S. financial markets. The Company will host a

Voir plus
Travere Therapeutics to Report Third Quarter 2025 Financial Results

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.